“Pothead” could one day get a whole new meaning. A new study suggests low doses of THC, the main psychoactive ingredient in ...

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...

In A Nutshell A mouse study found that low-dose THC combined with celecoxib protected memory and reduced brain damage linked to Alzheimer’s. THC alone reduced toxic proteins but also increased ...

Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART), according to new research from Texas Biomedical Research Institute. THC ...

Is marijuana getting too high on its own promises? New research published Monday adds to the evidence that medical cannabis ...

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated review ...

A comprehensive review of clinical trials finds little convincing evidence that cannabis-based medicines provide real relief for chronic nerve pain.

The two main compounds in cannabis are in a constant balancing act. This is an Inside Science story. (Inside Science) -- Many people who use cannabis do it for the euphoric effects caused by the main ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...

A compound found in marijuana can treat schizophrenia as effectively as antipsychotic medications, with far fewer side effects, according to a preliminary clinical trial. Researchers led by Markus ...